← Back to Search

Behavioural Intervention

Epilepsy Cohort for Epilepsy

N/A
Recruiting
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up epilepsy patients: 10 days; depression: 2 weeks
Awards & highlights

Study Summary

This trial aims to better understand depression by studying brain activity in patients with epilepsy and treatment-resistant depression. The researchers are using advanced artificial intelligence techniques to analyze the data and develop new treatment strategies. Their goal

Who is the study for?
This trial is for adults with refractory epilepsy scheduled for seizure monitoring and patients already enrolled in a deep brain stimulation (DBS) trial for treatment-resistant depression. Participants must consent to the study.Check my eligibility
What is being tested?
The study tests how brain activity relates to mood states using intracranial recordings and stimulation, alongside advanced AI models. It aims to improve understanding of depression's neurobiology and refine neuromodulatory treatments.See study design
What are the potential side effects?
While specific side effects are not listed, brain stimulation procedures may include risks such as discomfort at the electrode site, headache, nausea, or other potential neurological effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~epilepsy patients: 10 days; depression: 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and epilepsy patients: 10 days; depression: 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Daily Mood Assessment - CAT-DI
Secondary outcome measures
Intracranial EEG Neural Recordings for Mood and Behavioral Assessments

Trial Design

2Treatment groups
Experimental Treatment
Group I: Epilepsy CohortExperimental Treatment1 Intervention
Group II: Depression CohortExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of MinnesotaOTHER
1,381 Previous Clinical Trials
1,551,226 Total Patients Enrolled
12 Trials studying Epilepsy
473 Patients Enrolled for Epilepsy
Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,354 Total Patients Enrolled
4 Trials studying Epilepsy
309 Patients Enrolled for Epilepsy
University of TexasOTHER
187 Previous Clinical Trials
142,395 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals who are 85 years of age and older eligible to participate in this trial?

"To be eligible for inclusion in this study, participants must range from 21 to 70 years old."

Answered by AI

Can individuals such as myself participate in this clinical study?

"The research study aims to recruit 58 individuals diagnosed with epilepsy, aged between 21 and 70. Specifically, eligible participants include adults planning intracranial seizure monitoring after giving informed consent for the Epilepsy cohort and those currently engaged in our Deep Brain Stimulation (DBS) trial for depression within the Depression cohort."

Answered by AI

What is the overall count of individuals involved in this research endeavor?

"Indeed, information sourced from clinicaltrials.gov reveals that this investigation is actively seeking eligible participants. Initially shared on 7th March 2023 and last revised on 4th April 2024, the trial aims to enroll a total of 58 individuals across one designated site."

Answered by AI
~39 spots leftby Mar 2028